Oral bacterium tied to disability severity in multiple sclerosis
Peer-Reviewed Publication
Updates every hour. Last Updated: 16-Jun-2026 21:15 ET (17-Jun-2026 01:15 GMT/UTC)
Findings connect Fusobacterium nucleatum with multiple sclerosis disease severity
Researchers at the University of Cologne discovered a new mechanism used by one of the most aggressive forms of lung cancer to escape treatment, paving the way for more efficient future therapies / publication in “Nature Communications”
A new international study led by the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds: melanoma cancer cells paralyze immune cells by secreting extracellular vesicles (EVs), which are tiny, bubble-shaped containers secreted from a given cell. The research team believes that this discovery has far-reaching implications for possible treatments for the deadliest form of skin cancer.
The therapeutic use of human calcitonin (CT) in humans is limited by rapid receptor desensitization (tachyphylaxis), which requires short-term dosing despite the need for long-term treatment. In contrast, fish CT-CT receptors (CTR) exhibit extraordinary resistance to desensitization, enabling lifelong calcium regulation in high-Ca2+ marine environments. Here, we analyze the evolutionary, structural, and functional distinctions between fish and human CT systems. We propose that the unique molecular structure of fish CT and CTR may provide templates for engineering durable therapeutic agents to overcome tachyphylaxis.
Study shows tooth loss, not low-protein intake, drives memory decline in aging mice, hinting that reduced chewing may influence brain health.